Guidance

Wholesalers & manufacturers guidance following agreement of the Windsor Framework

Actions QPs, RPis and RPs need to take following agreement of the Windsor Framework

• From: Medicines and Healthcare products Regulatory Agency
• Published: 12 September 2024
• Last updated: 20 February 2025 — See all updates

Documents

Wholesalers' and manufacturers' guidance following agreement of the Windsor Framework

HTML

Windsor Framework disapplication of EU falsified medicines directive Q&A

PDF, 276 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Windsor Framework wholesaler and manufacturer Q&A

PDF, 323 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Guidance to support manufacturers and wholesale dealers authorised by the MHRA and the associated qualified persons (QPs), responsible persons (RPs) and responsible persons for import (RPis), in order to implement the arrangements of the Windsor Framework for human medicines.

Published 12 September 2024
Last updated 20 February 2025 + show all updates

1. 20 February 2025

   Updated the document Wholesalers & manufacturers guidance following agreement of the Windsor Framework to add Windsor Framework Wholesaler and Manufacturers Q&A and FMD Q&A

2. 12 September 2024

   First published.